Keshavan MS, Morris DW, Sweeney JA, Pearlson G, Thaker G, Seidman LJ, et al. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr Res. 2011;133:250–54.

Article  PubMed  PubMed Central  Google Scholar 

Fischer BA, Carpenter WT Jr. Will the Kraepelinian dichotomy survive DSM-V? Neuropsychopharmacology. 2009;34:2081–7.

Article  PubMed  PubMed Central  Google Scholar 

American Psychiatric A. Diagnostic and statistical manual of mental disorders. 5th, text rev. edn. Washington, DC: American Psychiatric Association Publishing, 2022.

Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aminoff SR, Onyeka IN, Odegaard M, Simonsen C, Lagerberg TV, Andreassen OA, et al. Lifetime and point prevalence of psychotic symptoms in adults with bipolar disorders: a systematic review and meta-analysis. Psychol Med. 2022;52:2413–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sole E, Garriga M, Valenti M, Vieta E. Mixed features in bipolar disorder. CNS Spectr. 2017;22:134–40.

Article  PubMed  Google Scholar 

Schmitt A, Falkai P, Papiol S. Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors. J Neural Transm (Vienna). 2023;130:195–205.

Article  PubMed  Google Scholar 

De Picker LJ, Morrens M, Branchi I, Haarman BCM, Terada T, Kang MS, et al. TSPO PET brain inflammation imaging: A transdiagnostic systematic review and meta-analysis of 156 case-control studies. Brain Behav Immun. 2023;113:415–31.

Article  PubMed  Google Scholar 

Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696–709.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang AK, Miller BJ. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. 2018;44:75–83.

Article  PubMed  PubMed Central  Google Scholar 

Rømer TB, Jeppesen R, Christensen RHB, Benros ME. Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis. Mol Psychiatry. 2023;28:2277–90.

Article  PubMed  Google Scholar 

Hughes HK, Ashwood P. Overlapping evidence of innate immune dysfunction in psychotic and affective disorders. Brain Behav Immun Health. 2020;2:100038.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Steiner J, Bogerts B, Sarnyai Z, Walter M, Gos T, Bernstein HG, et al. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. World J Biol Psychiatry. 2012;13:482–92.

Article  PubMed  Google Scholar 

Bernstein HG, Steiner J, Guest PC, Dobrowolny H, Bogerts B. Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr Res. 2015;161:4–18.

Article  PubMed  Google Scholar 

Brisch R, Wojtylak S, Saniotis A, Steiner J, Gos T, Kumaratilake J, et al. The role of microglia in neuropsychiatric disorders and suicide. Eur Arch Psychiatry Clin Neurosci. 2022;272:929–45.

Article  PubMed  Google Scholar 

Rahimian R, Wakid M, O’Leary LA, Mechawar N. The emerging tale of microglia in psychiatric disorders. Neurosci Biobehav Rev. 2021;131:1–29.

Article  PubMed  Google Scholar 

Laricchiuta D, Papi M, Decandia D, Panuccio A, Cutuli D, Peciccia M, et al. The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects. Front Cell Neurosci. 2024;18:1358450.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bernstein HG, Nussbaumer M, Vasilevska V, Dobrowolny H, Nickl-Jockschat T, Guest PC, et al. Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration. Mol Psychiatry. 2024.

Liu SH, Du Y, Chen L, Cheng Y. Glial cell abnormalities in major psychiatric diseases: a systematic review of postmortem brain studies. Mol Neurobiol. 2022;59:1665–92.

Article  CAS  PubMed  Google Scholar 

Amor S, McNamara NB, Gerrits E, Marzin MC, Kooistra SM, Miron VE, et al. White matter microglia heterogeneity in the CNS. Acta Neuropathol. 2022;143:125–41.

Article  PubMed  Google Scholar 

Beydoun MA, Obhi HK, Weiss J, Canas JA, Beydoun HA, Evans MK, et al. Systemic inflammation is associated with depressive symptoms differentially by sex and race: a longitudinal study of urban adults. Mol Psychiatry. 2020;25:1286–1300.

Article  PubMed  Google Scholar 

Mondelli V, Blackman G, Kempton MJ, Pollak TA, Iyegbe C, Valmaggia LR, et al. Serum immune markers and transition to psychosis in individuals at clinical high risk. Brain Behav Immun. 2023;110:290–6.

Article  CAS  PubMed  Google Scholar 

Ouyang L, Li D, Li Z, Ma X, Yuan L, Fan L, et al. IL-17 and TNF-beta: Predictive biomarkers for transition to psychosis in ultra-high risk individuals. Front Psychiatry. 2022;13:1072380.

Article  PubMed  PubMed Central  Google Scholar 

Lamers F, Milaneschi Y, Smit JH, Schoevers RA, Wittenberg G, Penninx B. Longitudinal association between depression and inflammatory markers: results from the netherlands study of depression and anxiety. Biol Psychiatry. 2019;85:829–37.

Article  PubMed  Google Scholar 

van Kesteren CF, Gremmels H, de Witte LD, Hol EM, Van Gool AR, Falkai PG, et al. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry. 2017;7:e1075.

Article  PubMed  PubMed Central  Google Scholar 

Snijders G, van Zuiden W, Sneeboer MAM, Berdenis van Berlekom A, van der Geest AT, Schnieder T, et al. A loss of mature microglial markers without immune activation in schizophrenia. Glia. 2021;69:1251–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Enache D, Pariante CM, Mondelli V. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun. 2019;81:24–40.

Article  PubMed  Google Scholar 

Fillman SG, Sinclair D, Fung SJ, Webster MJ, Shannon Weickert C. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry. 2014;4:e365.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schlaaff K, Dobrowolny H, Frodl T, Mawrin C, Gos T, Steiner J, et al. Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients. Brain Behav Immun. 2020;88:497–506.

Article  CAS  PubMed  Google Scholar 

Zhu Y, Owens SJ, Murphy CE, Ajulu K, Rothmond D, Purves-Tyson T, et al. Inflammation-related transcripts define “high” and “low” subgroups of individuals with schizophrenia and bipolar disorder in the midbrain. Brain Behav Immun. 2022;105:149–59.

Article  CAS  PubMed  Google Scholar 

Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019;49:1958–70.

Article  PubMed  PubMed Central  Google Scholar 

Riester K, Brawek B, Savitska D, Frohlich N, Zirdum E, Mojtahedi N, et al. In vivo characterization of functional states of cortical microglia during peripheral inflammation. Brain Behav Immun. 2020;87:243–55.

Article  CAS  PubMed  Google Scholar